Devyser was founded in 2004 in Stockholm, Sweden, specialises in the development of genetic diagnostic tests for hereditary diseases, oncology, and transplantation, based on multiplexed PCR and QF-PCR technology. Their non-invasive products are well intended for guided targeted cancer therapies, rapid pre-natal diagnostics and post-transplantation monitoring.